Leave Your Message

Clinical Service Center has reached a strategic cooperation agreement with the Second Affiliated Hospital of Suzhou University.

Mutual Cooperation - Innovative Integration

On April 19, 2023, a cooperative exchange meeting themed "Mutual Cooperation - Innovative Integration" was jointly organized by theSecond Affiliated Hospital of Suzhou University, Suzhou Biomedical Industry Park (BioBAY), and the Suzhou Clinical Research Services Platform. The event, guided by the Suzhou Municipal Health Commission, took place at the Jinji Lake Exhibition Center in Suzhou. Clinical Service Center, represented by Beijing Clinical Service Center Medical Research Co., Ltd., was invited to participate in the conference. During the event, comprehensive and in-depth collaboration discussions were conducted with theSecond Affiliated Hospital of Suzhou University on various aspects, including innovative drug clinical research, global drug regulatory policy exchange, exploration of digitalization in clinical research, innovative therapies, and the establishment of a regulatory system for dual-reporting varieties between China and the United States. The collaboration resulted in the successful signing of a strategic cooperation framework agreement. The signing ceremony was witnessed by leaders from the Suzhou Municipal Health Commission, the Innovation Cooperation Department of the Industrial Park Science and Technology Investment Center, and other distinguished guests.

Vice President Qian Zhiyuan of theSecond Affiliated Hospital of Suzhou University and Mr. Xu Yu, CEO of Clinical Service Center, signed the strategic cooperation agreement. Nearly a hundred experts, including representatives from enterprises, and professionals from various departments such as clinical trial institutions, Phase I Clinical Trial Center, Urology Department, Hematology Department, Neurology Department, Endocrinology Department, Gastroenterology Department, Rheumatology and Immunology Department, and Oncology Department at the Second Affiliated Hospital of Suzhou University, jointly witnessed this important moment.


Established in 1988, the Second Affiliated Hospital of Suzhou University is a tertiary Grade A hospital integrating medical care, teaching, research, prevention, and emergency services. It is also the Fourth Clinical Department of the National Health Commission's Emergency Center for Nuclear Accidents, a national clinical medicine postdoctoral mobile station, and the granting point for doctoral and master's degrees in clinical medicine. The hospital is a standardized training base for resident physicians and a national drug clinical trial base. It houses several research centers, including the Clinical Center of the State Key Laboratory of Radiobiology and Radiation Protection, the Jiangsu Provincial Engineering Research Center for Promoting the Application of Sports Medicine in Elderly Bone Health, the Jiangsu Provincial Engineering Research Center for the Diagnosis and Treatment of Neurological Diseases, and the Jiangsu Provincial Key Laboratory for Osteoporosis Diagnosis and Treatment Technology and Transformation. Additionally, it serves as the clinical medical center for radiation therapy, neurological diseases, neurosurgery, orthopedics, and osteoporosis in Suzhou. The hospital has four research institutes affiliated with Soochow University and ten city key laboratories.

Beijing Clinical Service Center Medical Research Co., Ltd. is a comprehensive medical technology service provider dedicated to clinical operations, drug regulatory registration, medical writing, biostatistics and data management, drug vigilance, call center services, quality assurance, training, and consulting.


Headquartered in Beijing, Clinical Service Center has physical offices in Shanghai, Guangzhou, Tianjin, Chengdu, Xi'an, Shenyang, Suzhou, Nanjing, Taipei, and presence in more than 20 cities with on-site monitors. Overseas offices are established in the United States, the United Kingdom, Canada, Singapore, and other locations. Currently, it boasts an international team of over 800 professionals.

Since its establishment in 2009, Clinical Service Center has actively participated in clinical research and academic promotion in the field of medicine, both domestically and internationally. The organization provides specialized clinical services to pharmaceutical companies, authoritative academic institutions, clinical trial research institutions, experts, and physicians. This effort aims to contribute to the health of patients and society. With high-quality service, reasonable prices, and rapid growth, Clinical Service Center has become one of China's major clinical trial contract research organizations. The organization's high customer retention rate of 85% is attributed to its highly qualified team, well-established quality management system, efficient and high-quality services, and extensive clinical research experience.

Our clients and partners include domestic and international pharmaceutical, biotechnology, and medical device companies, as well as academic and government organizations. By applying advanced clinical trial concepts and technologies, along with clinical treatment expertise and high-quality service, we help clients and partners carry out clinical trial projects. This accelerates the development of safe and effective medical products and maximizes the return on investment in pharmaceutical research and development. As a result, we have accumulated rich clinical research experience in many medical fields, such as oncology and cardiovascular diseases.

Our senior management team and appointed consultants have extensive experience in the pharmaceutical industry, both domestically and internationally. They enjoy a certain level of expertise and reputation in the field of international and domestic clinical trials."